Suppr超能文献

用于监测典型半乳糖血症的IgG N-糖基化半乳糖掺入率

IgG N-Glycosylation Galactose Incorporation Ratios for the Monitoring of Classical Galactosaemia.

作者信息

Stockmann Henning, Coss Karen P, Rubio-Gozalbo M Estela, Knerr Ina, Fitzgibbon Maria, Maratha Ashwini, Wilson James, Rudd Pauline, Treacy Eileen P

机构信息

National Institute for Bioprocessing Research and Training (NIBRT), Glycoscience Group, Mount Merrion, Blackrock, Dublin University College, Dublin, Ireland.

Department of Infectious Diseases, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, UK.

出版信息

JIMD Rep. 2016;27:47-53. doi: 10.1007/8904_2015_490. Epub 2015 Sep 30.

Abstract

Classical galactosaemia (OMIM #230400) is a rare disorder of carbohydrate metabolism caused by deficiency of the galactose-1-phosphate uridyltransferase enzyme (EC 2.7.7.12). The cause of the long-term complications, including neurological, cognitive and fertility problems in females, remains poorly understood. The relatively small number of patients with galactosaemia and the lack of validated biomarkers pose a substantial challenge for determining prognosis and monitoring disease progression and responses to new therapies. We report an improved method of automated robotic hydrophilic interaction ultra-performance liquid chromatography N-glycan analysis for the measurement of IgG N-glycan galactose incorporation ratios applied to the monitoring of adult patients with classical galactosaemia. We analysed 40 affected adult patients and 81 matched healthy controls. Significant differences were noted between the G0/G1 and G0/G2 incorporation ratios between galactosaemia patients and controls (p < 0.001 and <0.01, respectively). Our data indicate that the use of IgG N-glycosylation galactose incorporation analysis may be now applicable for monitoring patient dietary compliance, determining prognosis and the evaluation of potential new therapies.

摘要

经典型半乳糖血症(OMIM #230400)是一种罕见的碳水化合物代谢紊乱疾病,由半乳糖-1-磷酸尿苷转移酶(EC 2.7.7.12)缺乏引起。包括女性的神经、认知和生育问题在内的长期并发症的病因仍知之甚少。半乳糖血症患者数量相对较少,且缺乏经过验证的生物标志物,这对确定预后、监测疾病进展以及对新疗法的反应构成了重大挑战。我们报告了一种改进的自动机器人亲水相互作用超高效液相色谱N-聚糖分析方法,用于测量IgG N-聚糖半乳糖掺入率,该方法应用于监测成年经典型半乳糖血症患者。我们分析了40名受影响的成年患者和81名匹配的健康对照。半乳糖血症患者与对照组之间的G0/G1和G0/G2掺入率存在显著差异(分别为p < 0.001和<0.01)。我们的数据表明,IgG N-糖基化半乳糖掺入分析现在可能适用于监测患者的饮食依从性、确定预后以及评估潜在的新疗法。

相似文献

8
N-glycan abnormalities in children with galactosemia.半乳糖血症患儿的N-聚糖异常
J Proteome Res. 2014 Feb 7;13(2):385-94. doi: 10.1021/pr4008305. Epub 2013 Dec 20.
10
Classical galactosaemia revisited.经典型半乳糖血症再探讨。
J Inherit Metab Dis. 2006 Aug;29(4):516-25. doi: 10.1007/s10545-006-0382-0. Epub 2006 Jul 11.

引用本文的文献

3
Immunoglobulin G Glycosylation in Diseases.免疫球蛋白 G 糖基化在疾病中的作用。
Exp Suppl. 2021;112:395-431. doi: 10.1007/978-3-030-76912-3_13.

本文引用的文献

4
N-glycan abnormalities in children with galactosemia.半乳糖血症患儿的N-聚糖异常
J Proteome Res. 2014 Feb 7;13(2):385-94. doi: 10.1021/pr4008305. Epub 2013 Dec 20.
5
6
Understanding human glycosylation disorders: biochemistry leads the charge.理解人类糖基化紊乱:生物化学引领研究。
J Biol Chem. 2013 Mar 8;288(10):6936-45. doi: 10.1074/jbc.R112.429274. Epub 2013 Jan 17.
7
N- and O-linked glycosylation of total plasma glycoproteins in galactosemia.半乳糖血症患者血浆糖蛋白的 N-和 O-糖基化。
Mol Genet Metab. 2012 Aug;106(4):442-54. doi: 10.1016/j.ymgme.2012.05.025. Epub 2012 Jun 12.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验